BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,664,058 | +4.2% | 24,238 | +0.4% | 0.00% | +50.0% |
| Q2 2022 | $3,516,711 | +35.7% | 24,135 | +10.4% | 0.00% | 0.0% |
| Q1 2022 | $2,591,110 | -30.5% | 21,853 | -19.3% | 0.00% | 0.0% |
| Q4 2021 | $3,730,000 | -2.0% | 27,068 | -1.3% | 0.00% | -33.3% |
| Q3 2021 | $3,808,000 | +34.1% | 27,413 | -6.3% | 0.00% | +50.0% |
| Q2 2021 | $2,840,000 | +58.9% | 29,255 | +11.9% | 0.00% | 0.0% |
| Q1 2021 | $1,787,000 | -24.9% | 26,142 | -5.8% | 0.00% | 0.0% |
| Q4 2020 | $2,380,000 | +36.9% | 27,766 | +3.8% | 0.00% | 0.0% |
| Q3 2020 | $1,739,000 | -7.2% | 26,746 | -1.1% | 0.00% | 0.0% |
| Q2 2020 | $1,874,000 | +117.4% | 27,033 | +6.7% | 0.00% | +100.0% |
| Q1 2020 | $862,000 | -16.0% | 25,333 | +12.9% | 0.00% | 0.0% |
| Q4 2019 | $1,026,000 | +8.3% | 22,439 | -1.6% | 0.00% | 0.0% |
| Q3 2019 | $947,000 | +9.2% | 22,805 | +15.2% | 0.00% | 0.0% |
| Q2 2019 | $867,000 | -13.8% | 19,802 | +1.3% | 0.00% | 0.0% |
| Q1 2019 | $1,006,000 | +56.7% | 19,544 | +12.5% | 0.00% | 0.0% |
| Q4 2018 | $642,000 | -5.2% | 17,366 | -3.7% | 0.00% | 0.0% |
| Q3 2018 | $677,000 | -12.9% | 18,025 | -8.4% | 0.00% | 0.0% |
| Q2 2018 | $777,000 | +31.9% | 19,671 | -13.9% | 0.00% | 0.0% |
| Q1 2018 | $589,000 | +174.0% | 22,859 | +186.2% | 0.00% | – |
| Q4 2017 | $215,000 | -27.9% | 7,986 | 0.0% | 0.00% | – |
| Q3 2017 | $298,000 | +52.0% | 7,986 | +2.3% | 0.00% | – |
| Q2 2017 | $196,000 | – | 7,805 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |